Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.03 AUD | -0.82% | +1.35% | -1.64% |
Apr. 30 | Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases | MT |
Apr. 24 | Germany's Evotec Appoints Permanent CEO | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.64% | 1.3B | |
+6.68% | 4.27B | |
+23.28% | 2.08B | |
-.--% | 1.82B | |
-20.17% | 1.54B | |
-9.96% | 1.16B | |
-18.52% | 1.13B | |
-47.88% | 882M | |
-.--% | 818M | |
+0.87% | 527M |
- Stock Market
- Equities
- EVT Stock
- News EVT Limited
- Jarden Adjusts EVT’s Price Target to AU$11.31 From AU$12.55, Keeps at Overweight